FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990249229> ?p ?o ?g. }

• W1990249229 endingPage "1649" @default.
• W1990249229 startingPage "1649" @default.
• W1990249229 abstract "The BRAF inhibitor (BRAFi) treatment has led to impressive responses in BRAF(V600E) mutation-positive melanomas, but responses are not durable in many patients. As most of the BRAFi escape mechanisms involve ERK reactivation, combinations with MEK inhibitors (MEKi) are currently tested to improve BRAFi-mediated response durations. Additionally, such a combination is expected to reduce MEKi-induced skin toxicities, as these drugs are thought to have antagonistic effects on ERK activation in keratinocytes. However, preclinical in vivo data exploring the combination of BRAFi and MEKi to achieve improved tumor control in the absence of skin toxicities are limited. Using a murine Tyr::CreER(T2);Pten(LoxP/LoxP);Braf(CA/+) melanoma model, we have determined the effect of BRAFi and MEKi treatment and their combination on melanoma control and occurrence of adverse events. We found that the MEKi dosed beyond the maximum tolerable dose (MTD) led to stronger control of tumor growth than did the BRAFi, but mice had to be removed from treatment because of skin toxicity. The combination of BRAFi and MEKi reduced MEKi-associated skin toxicity. This allowed high and long-term dosing of the MEKi, resulting in long-term tumor control. In contrast to previous hypotheses, the addition of a BRAFi did not restore the MEKi-mediated downregulation of pERK1/2 in skin cells. Our data describe, for the first time, the alleviation of MEKi-mediated dose-limiting toxicity by addition of a BRAFi in a mouse melanoma model. Additional clinical Phase I studies should be implemented to explore MEKi dosing beyond the single drug MTD in combination with BRAFi." @default.
• W1990249229 created "2016-06-24" @default.
• W1990249229 creator A5037222040 @default.
• W1990249229 creator A5053620374 @default.
• W1990249229 creator A5079846321 @default.
• W1990249229 creator A5088390068 @default.
• W1990249229 date "2013-11-01" @default.
• W1990249229 modified "2023-10-16" @default.
• W1990249229 title "Synchronous BRAFV600E and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity" @default.
• W1990249229 cites W1966510725 @default.
• W1990249229 cites W1970039331 @default.
• W1990249229 cites W1970195561 @default.
• W1990249229 cites W1986258970 @default.
• W1990249229 cites W1988379285 @default.
• W1990249229 cites W1990376228 @default.
• W1990249229 cites W1991708036 @default.
• W1990249229 cites W2001256555 @default.
• W1990249229 cites W2024085992 @default.
• W1990249229 cites W2044381241 @default.
• W1990249229 cites W2050206485 @default.
• W1990249229 cites W2052781279 @default.
• W1990249229 cites W2096046981 @default.
• W1990249229 cites W2124301770 @default.
• W1990249229 cites W2127132608 @default.
• W1990249229 cites W2128542677 @default.
• W1990249229 cites W2131919057 @default.
• W1990249229 cites W2134471382 @default.
• W1990249229 cites W2134758896 @default.
• W1990249229 cites W2136474966 @default.
• W1990249229 cites W2141830999 @default.
• W1990249229 cites W2142859055 @default.
• W1990249229 cites W2154196978 @default.
• W1990249229 cites W2156078931 @default.
• W1990249229 cites W2163655212 @default.
• W1990249229 cites W2170138574 @default.
• W1990249229 cites W2268296423 @default.
• W1990249229 cites W2998895464 @default.
• W1990249229 doi "https://doi.org/10.2147/ott.s52552" @default.
• W1990249229 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3849083" @default.
• W1990249229 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24348046" @default.
• W1990249229 hasPublicationYear "2013" @default.
• W1990249229 type Work @default.
• W1990249229 sameAs 1990249229 @default.
• W1990249229 citedByCount "9" @default.
• W1990249229 countsByYear W19902492292014 @default.
• W1990249229 countsByYear W19902492292015 @default.
• W1990249229 countsByYear W19902492292016 @default.
• W1990249229 countsByYear W19902492292017 @default.
• W1990249229 countsByYear W19902492292018 @default.
• W1990249229 countsByYear W19902492292019 @default.
• W1990249229 countsByYear W19902492292021 @default.
• W1990249229 countsByYear W19902492292022 @default.
• W1990249229 crossrefType "journal-article" @default.
• W1990249229 hasAuthorship W1990249229A5037222040 @default.
• W1990249229 hasAuthorship W1990249229A5053620374 @default.
• W1990249229 hasAuthorship W1990249229A5079846321 @default.
• W1990249229 hasAuthorship W1990249229A5088390068 @default.
• W1990249229 hasBestOaLocation W19902492291 @default.
• W1990249229 hasConcept C104317684 @default.
• W1990249229 hasConcept C126322002 @default.
• W1990249229 hasConcept C127413603 @default.
• W1990249229 hasConcept C127561419 @default.
• W1990249229 hasConcept C150903083 @default.
• W1990249229 hasConcept C184235292 @default.
• W1990249229 hasConcept C185592680 @default.
• W1990249229 hasConcept C188198153 @default.
• W1990249229 hasConcept C197934379 @default.
• W1990249229 hasConcept C207001950 @default.
• W1990249229 hasConcept C2777288759 @default.
• W1990249229 hasConcept C2777658100 @default.
• W1990249229 hasConcept C2781249067 @default.
• W1990249229 hasConcept C29730261 @default.
• W1990249229 hasConcept C502942594 @default.
• W1990249229 hasConcept C55493867 @default.
• W1990249229 hasConcept C57074206 @default.
• W1990249229 hasConcept C71924100 @default.
• W1990249229 hasConcept C78519656 @default.
• W1990249229 hasConcept C86803240 @default.
• W1990249229 hasConcept C98274493 @default.
• W1990249229 hasConceptScore W1990249229C104317684 @default.
• W1990249229 hasConceptScore W1990249229C126322002 @default.
• W1990249229 hasConceptScore W1990249229C127413603 @default.
• W1990249229 hasConceptScore W1990249229C127561419 @default.
• W1990249229 hasConceptScore W1990249229C150903083 @default.
• W1990249229 hasConceptScore W1990249229C184235292 @default.
• W1990249229 hasConceptScore W1990249229C185592680 @default.
• W1990249229 hasConceptScore W1990249229C188198153 @default.
• W1990249229 hasConceptScore W1990249229C197934379 @default.
• W1990249229 hasConceptScore W1990249229C207001950 @default.
• W1990249229 hasConceptScore W1990249229C2777288759 @default.
• W1990249229 hasConceptScore W1990249229C2777658100 @default.
• W1990249229 hasConceptScore W1990249229C2781249067 @default.
• W1990249229 hasConceptScore W1990249229C29730261 @default.
• W1990249229 hasConceptScore W1990249229C502942594 @default.
• W1990249229 hasConceptScore W1990249229C55493867 @default.
• W1990249229 hasConceptScore W1990249229C57074206 @default.
• W1990249229 hasConceptScore W1990249229C71924100 @default.
• W1990249229 hasConceptScore W1990249229C78519656 @default.

• next